Dolby Laboratories Inc [DLB] stock prices are up 0.93% to $74.99 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The DLB shares have gain 3.18% over the last week, with a monthly amount glided 5.52%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Dolby Laboratories Inc [NYSE: DLB] stock has seen the most recent analyst activity on June 03, 2024, when Barrington Research upgraded its rating to a Outperform but kept the price target unchanged to $100 for it. Previously, Barrington Research downgraded its rating to Mkt Perform on November 18, 2022. On May 24, 2022, Rosenblatt initiated with a Buy rating and assigned a price target of $90 on the stock. Barrington Research upgraded its rating to a Outperform but stick to its price target of $115 on August 02, 2021. B. Riley FBR reiterated its recommendation of a Neutral and raised its price target to $73 on August 04, 2020. B. Riley FBR downgraded its rating to Neutral for this stock on June 24, 2020, and upped its price target to $72. In a note dated March 24, 2020, B. Riley FBR upgraded an Buy rating on this stock and boosted its target price from $57 to $60.
The stock price of Dolby Laboratories Inc [DLB] has been fluctuating between $66.35 and $90.06 over the past year. Currently, Wall Street analysts expect the stock to reach $90 within the next 12 months. Dolby Laboratories Inc [NYSE: DLB] shares were valued at $74.99 at the most recent close of the market. An investor can expect a potential return of 20.02% based on the average DLB price forecast.
Analyzing the DLB fundamentals
The Dolby Laboratories Inc [NYSE:DLB] reported sales of 1.26B for trailing twelve months, representing a drop of -3.20%. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.05 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.21 points at the first support level, and at 73.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 75.50, and for the 2nd resistance point, it is at 76.02.
Ratios To Look Out For
It’s worth pointing out that Dolby Laboratories Inc [NYSE:DLB]’s Current Ratio is 4.14. On the other hand, the Quick Ratio is 4.04, and the Cash Ratio is 1.77. Considering the valuation of this stock, the price to sales ratio is 5.68, the price to book ratio is 2.95 and price to earnings (TTM) ratio is 34.27.
Transactions by insiders
Recent insider trading involved YEAMAN KEVIN J, President and CEO, that happened on Jun 17 ’24 when 3.0 shares were purchased. EVP, Gen. Counsel & Secretary, SHERMAN MARK ANDREW completed a deal on May 28 ’24 to sell 2283.0 shares. Meanwhile, Director Rollins Emily sold 1000.0 shares on Mar 01 ’24.
